bioMérieux S.A. (VIE:BIM)
Austria · Delayed Price · Currency is EUR 98.55
-0.25 (-0.25%)
At close: Jan 29, 2026
bioMérieux Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 377.9 | 432.2 | 357.6 | 452.4 | 601.1 | 404.4 |
Depreciation & Amortization | 346.2 | 344.2 | 318.3 | 268.5 | 219.5 | 208.8 |
Other Amortization | 16.3 | 16.3 | 15.7 | 18.1 | - | 19.6 |
Asset Writedown & Restructuring Costs | 168.4 | 22.9 | 129.6 | 29 | 28.3 | 17.5 |
Loss (Gain) From Sale of Investments | - | - | - | - | -0.6 | 0.6 |
Loss (Gain) on Equity Investments | - | - | - | - | 0.7 | 0.2 |
Stock-Based Compensation | 24.7 | 23.4 | 19.7 | 13 | 12.4 | 9.9 |
Other Operating Activities | -120.5 | -120.7 | -192.2 | -150 | -13.9 | 2.5 |
Change in Accounts Receivable | -30.1 | -53.7 | -13.7 | -145.6 | 23.6 | -80.4 |
Change in Inventory | -26.1 | -85.1 | -192.6 | -92.1 | -48.8 | -82.9 |
Change in Accounts Payable | 15.6 | -0.6 | 3.4 | 9.9 | 24.2 | 4.7 |
Change in Other Net Operating Assets | 15.3 | 88.4 | -0.4 | 71.9 | -21.8 | 77.9 |
Operating Cash Flow | 787.7 | 667.3 | 445.4 | 475.1 | 824.7 | 582.8 |
Operating Cash Flow Growth | 59.26% | 49.82% | -6.25% | -42.39% | 41.51% | 42.88% |
Capital Expenditures | -348.3 | -345.8 | -338.3 | -286.7 | -290.1 | -277.5 |
Sale of Property, Plant & Equipment | 10.9 | 9.4 | 6.4 | 17.4 | 20 | 24.7 |
Cash Acquisitions | -131.2 | -8.8 | - | -205 | -33.5 | -10.1 |
Investment in Securities | -2.3 | -14.6 | -156.9 | -53.8 | -3.7 | -2.3 |
Investing Cash Flow | -471 | -359.8 | -488.8 | -528.1 | -307.3 | -265.2 |
Long-Term Debt Issued | - | 9.8 | 38.9 | 67.7 | 18.2 | 292 |
Long-Term Debt Repaid | - | -84.6 | -73.7 | -53.4 | -68.3 | -426.5 |
Net Debt Issued (Repaid) | -67.8 | -74.8 | -34.8 | 14.3 | -50.1 | -134.5 |
Issuance of Common Stock | 16.4 | - | 12.7 | - | - | - |
Repurchase of Common Stock | -16.4 | -37.6 | - | -157.2 | -17.4 | -18.4 |
Common Dividends Paid | - | - | - | -101.2 | -73.1 | -22.5 |
Other Financing Activities | -106 | -100.2 | -100.2 | -0.1 | - | -0.8 |
Financing Cash Flow | -173.8 | -212.6 | -122.3 | -244.2 | -140.6 | -176.2 |
Foreign Exchange Rate Adjustments | -38.4 | 13.9 | -29.7 | 38.7 | 39.2 | -34.1 |
Miscellaneous Cash Flow Adjustments | - | - | - | -0.1 | - | - |
Net Cash Flow | 104.5 | 108.8 | -195.4 | -258.6 | 416 | 107.3 |
Free Cash Flow | 439.4 | 321.5 | 107.1 | 188.4 | 534.6 | 305.3 |
Free Cash Flow Growth | 180.95% | 200.19% | -43.15% | -64.76% | 75.11% | 125.48% |
Free Cash Flow Margin | 10.66% | 8.08% | 2.92% | 5.25% | 15.83% | 9.79% |
Free Cash Flow Per Share | 3.70 | 2.71 | 0.90 | 1.59 | 4.50 | 2.57 |
Cash Interest Paid | 15.4 | 16 | 15.8 | 4.1 | 9.1 | 24.9 |
Cash Income Tax Paid | 200.1 | 205.5 | 204.1 | 223.5 | 185.4 | 115.9 |
Levered Free Cash Flow | 530.15 | 297.79 | 152.25 | 206.36 | 389.05 | 282.65 |
Unlevered Free Cash Flow | 539.78 | 307.79 | 162.13 | 208.93 | 394.74 | 298.21 |
Change in Working Capital | -25.3 | -51 | -203.3 | -155.9 | -22.8 | -80.7 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.